Sanofi is done playing games with the fuckheads over at Medivation. Effective immediately, their $52.50 bid for the company, which is about $8 below the present market value of the shares, means they could replace the entire board of 8 useless morons with their own morons.
Medivation has a few Merck people, one Jazz Pharmaceutical retired exec, and several other medical wastrels doing nothing all– but getting in the way of Sanofi acquiring the company whole, in an all cash deal, for $9.3 billion.
Lastly, they’ve hired Goldman Sachs to advise them on how to proceed going forward. Ooh, scary!
Shares of MDVN are higher by 1% this morning.
If you enjoy the content at iBankCoin, please follow us on Twitter
